259750-61-3 Purity
98%
If you have any other questions or need other size, please get a quote.
Specification
Reference: [1]Le Manach, Claire; Paquet, Tanya; Gonzàlez Cabrera, Diego; Younis, Yassir; Taylor, Dale; Wiesner, Lubbe; Lawrence, Nina; Schwager, Sylva; Waterson, David; Witty, Michael J.; Wittlin, Sergio; Street, Leslie J.; Chibale, Kelly
[Journal of Medicinal Chemistry, 2014, vol. 57, # 21, p. 8839 - 8848]
Reference: [1]Patent: WO2006/101977,2006,A2 .Location in patent: Page/Page column 99
Reference: [1]Current Patent Assignee: KYMERA THERAPEUTICS INC - WO2020/10210, 2020, A1
Location in patent: Paragraph 00688; 00945
[2]Le Manach, Claire; Paquet, Tanya; Gonzàlez Cabrera, Diego; Younis, Yassir; Taylor, Dale; Wiesner, Lubbe; Lawrence, Nina; Schwager, Sylva; Waterson, David; Witty, Michael J.; Wittlin, Sergio; Street, Leslie J.; Chibale, Kelly
[Journal of Medicinal Chemistry, 2014, vol. 57, # 21, p. 8839 - 8848]
[3]Current Patent Assignee: KYMERA THERAPEUTICS INC - US2019/192668, 2019, A1
Location in patent: Paragraph 2524; 2526
* For details of the synthesis route, please refer to the original source to ensure accuracy.